Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117477525 | 11747752 | 5 | F | 201601 | 20160711 | 20151117 | 20160718 | EXP | US-PFIZER INC-2015393783 | PFIZER | 70.00 | YR | F | Y | 69.00000 | KG | 20160718 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117477525 | 11747752 | 1 | PS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | Y | M39808 | 203214 | 5 | MG | TABLET | BID | ||||
| 117477525 | 11747752 | 2 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | Y | 203214 | 5 | MG | TABLET | BID | |||||
| 117477525 | 11747752 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 40 MG, EVERY 2 WEEKS | 1053686 | 0 | 40 | MG | INJECTION | ||||||
| 117477525 | 11747752 | 4 | SS | HUMIRA | ADALIMUMAB | 1 | 0 | INJECTION | |||||||||||
| 117477525 | 11747752 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | 0 | TABLET | ||||||||||
| 117477525 | 11747752 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 5 MG, DAILY | 0 | 5 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117477525 | 11747752 | 1 | Rheumatoid arthritis |
| 117477525 | 11747752 | 3 | Rheumatoid arthritis |
| 117477525 | 11747752 | 4 | Psoriasis |
| 117477525 | 11747752 | 5 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117477525 | 11747752 | HO |
| 117477525 | 11747752 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117477525 | 11747752 | Arthropathy | |
| 117477525 | 11747752 | Blood pressure increased | |
| 117477525 | 11747752 | Condition aggravated | |
| 117477525 | 11747752 | Insomnia | |
| 117477525 | 11747752 | Psoriasis | |
| 117477525 | 11747752 | Rheumatoid arthritis | |
| 117477525 | 11747752 | Tendon injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117477525 | 11747752 | 1 | 2014 | 201601 | 0 | |
| 117477525 | 11747752 | 2 | 201602 | 20160316 | 0 | |
| 117477525 | 11747752 | 3 | 201603 | 0 | ||
| 117477525 | 11747752 | 5 | 2015 | 201601 | 0 | |
| 117477525 | 11747752 | 6 | 201601 | 0 |